Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Wait Pausing Investments

Sanofi is a French multinational healthcare company. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication.

Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Wait Pausing Investments

Top 100 largest companies in Russia by revenue

Top 100
Revenue(RF), mln.USD
692
Assets(RF), mln.USD
535
Capital(RF), mln.USD
435
Glob.Revenue, mln.USD
41415
Staff(RF), 2021
1548
Taxes(RF), mln.USD
83

In October 2009, Sanofi-Aventis bought a 74 percent stake in insulin manufacturer Bioton Vostok. This enterprise, located in Orel, was named Sanofi-Aventis Vostok and specializes in the production of insulins.

The Company Statement
March 23, 2022

The company stopped any new spending not related to the supply of the essential and life-changing medicines and vaccines in Russia, as well as in Belarus.

All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner